Search

Here’s a look at recent violations cited in FDA Warning Letters: fly pupae, cross contamination, trial dosing errors, and more.

We asked over 100 industry professionals for their views on the future of the pharma and biopharma industries.

Regulators want more pediatric formulations. Companies often turn to liquids, but there are specific challenges that need to be considered.

Shifting trends demand a change in how pharma field reps interact with healthcare professionals

How technology is enabling new access to clinical trials for those without the means to participate in traditional methods

The deadline for the US Drug Supply Chain Security Act is approaching.

With open minds and open sources, the future is foundational – and bright.

Digitalization can transform the operation and performance of the cell and gene therapy manufacturing space, to the benefit of all.

How metabolic conditioning could improve cell therapy potency and persistence.

AI is generating new drug discovery solutions for a rapidly changing industry